Video-Monitoring Could Be the Key to Making At-Home Addiction Treatment Safer and More Effective

Sebastian Seiguer, CEO of Scene Health, formerly emocha Health, and Dr. Kevin Hallgren of the University of Washington School of Medicine discuss the implications of video observation of methadone dosing for patient safety, policy and the behavioral health backlog. Dr. Hallgren is the lead author of a study published in the Journal of Substance Abuse Treatment (Oct 4, 2022), conducted in conjunction with Scene Health, that evaluated the feasibility, acceptability, and engagement with smartphone-based video observation of methadone take-home dosing.

Acceptability, feasibility, and outcomes of a clinical pilot program for video observation of methadone take-home dosing during the COVID-19 pandemic – Journal of Substance Abuse Treatment

Sebastian is the CEO and co-founder of Scene (previously emocha), a medication engagement company that provides personalized, breakthrough medication support by combining video technology, clinical coaching, and validated interventions to radically improve medication adherence rates. In 2014, Sebastian spun Scene out of Johns Hopkins with Dr. Bob Bollinger and other medication adherence experts to help communities served by public health departments, health plans including Medicaid and Medicare, and health systems. Scene is now the standard of care for infectious disease adherence monitoring and is scaling quickly. Sebastian started his career as an attorney with Allen & Overy in London before launching his first company in Munich, Germany, in 2000. He earned his law degree from Columbia Law School and his MBA in Health Care from Johns Hopkins University.

Liked it? Take a second to support healthprofessionalradio on Patreon!
Become a patron at Patreon!


Leave a Reply

You must be logged in to post a comment.